Skip to main content
logo
Enorama Pharma AB (publ) (STO:ERMA)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.4090
+0.0030 (0.74%)
May 26, 2026, 4:22 PM CET

Enorama Pharma AB Income Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3.862.7415.771.366.8512.8
Revenue Growth (YoY)
-76.25%-82.63%1061.12%-80.17%-46.50%186.40%
Cost of Revenue
9.4917.7812.075.267.468.9
Gross Profit
-5.63-15.043.7-3.9-0.623.9
Selling, General & Admin
49.946.6131.1334.3937.8329.99
Other Operating Expenses
0.37-0-0.24-0.01-0.02-0.15
Operating Expenses
50.6847.0851.337.9241.3531.23
Operating Income
-56.32-62.12-47.6-41.82-41.97-27.33
Interest Expense
--1.17-0.43-0.88-1.27-0.8
Interest & Investment Income
2.910.020.140.08--
Currency Exchange Gain (Loss)
-11.87-11.874.08-1.990.960.19
Other Non Operating Income (Expenses)
00---0.2
EBT Excluding Unusual Items
-65.27-75.14-43.81-44.61-42.28-27.74
Pretax Income
-65.27-75.14-43.81-44.61-42.03-27.74
Net Income
-65.27-75.14-43.81-44.61-42.03-27.74
Net Income to Common
-65.27-75.14-43.81-44.61-42.03-27.74
Shares Outstanding (Basic)
-69532886
Shares Outstanding (Diluted)
-69532886
Shares Change (YoY)
-30.99%91.50%253.96%26.23%11.44%
EPS (Basic)
--1.08-0.83-1.61-5.37-4.48
EPS (Diluted)
--1.08-0.83-1.61-5.37-4.48
Free Cash Flow
-45.27-59.26-35.7-41.35-32.96-30.22
Free Cash Flow Per Share
--0.85-0.67-1.49-4.21-4.88
Gross Margin
-146.11%-23.48%-287.26%-9.00%30.45%
Operating Margin
-1460.45%-2267.91%-301.87%-3079.82%-612.90%-213.52%
Profit Margin
-1692.76%-2743.30%-277.82%-3285.20%-613.85%-216.75%
Free Cash Flow Margin
-1173.88%-2163.60%-226.42%-3044.85%-481.35%-236.14%
EBITDA
-56.24-61.99-47.16-41.15-41.3-26.67
EBITDA Margin
---299.06%---208.34%
D&A For EBITDA
0.080.130.440.680.670.66
EBIT
-56.32-62.12-47.6-41.82-41.97-27.33
EBIT Margin
------213.52%
Revenue as Reported
--6.7427.611.129.4412.95
Source: S&P Global Market Intelligence. Standard template. Financial Sources.